Virgie Tovar: I think that her biggest concern was that just the existence of the medications themselves and the fact that doctors were suggesting them, were creating and perpetuating and perhaps worsening the message that something is wrong with your body when you're a kid
Muscle is essential for metabolic balance, as it takes up glucose, and losing muscle mass can lead to metabolic dysfunction
Allergic reactions: Rare but possible, especially for people with known sensitivities
Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
Die Einstichstelle wird mit dem Tupfer komprimiert
doi: 10.1016/j.neulet.2016.02.011